2007
DOI: 10.1016/j.jcv.2006.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of mumps-IgM ELISAs in acute infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
22
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(23 citation statements)
references
References 14 publications
(12 reference statements)
1
22
0
Order By: Relevance
“…The apparent higher rate of detection of IgM by the CDC assay than the commercial capture IgM test could be due to selection of the serum specimens chosen to evaluate and validate the tests. Although avidity testing has revealed that persons with a secondary immune response are capable of eliciting an IgM response, the IgM response appears to be variable and generally not as reactive in EIAs as that observed in a typical primary response (20)(21)(22)(23). Serum panels used to set the parameters for IgM detection (sensitivity) during the development of commercial assays are more likely to be collected from persons having a primary immune response and therefore have higher levels of IgM.…”
Section: Discussionmentioning
confidence: 99%
“…The apparent higher rate of detection of IgM by the CDC assay than the commercial capture IgM test could be due to selection of the serum specimens chosen to evaluate and validate the tests. Although avidity testing has revealed that persons with a secondary immune response are capable of eliciting an IgM response, the IgM response appears to be variable and generally not as reactive in EIAs as that observed in a typical primary response (20)(21)(22)(23). Serum panels used to set the parameters for IgM detection (sensitivity) during the development of commercial assays are more likely to be collected from persons having a primary immune response and therefore have higher levels of IgM.…”
Section: Discussionmentioning
confidence: 99%
“…The critical time appears to be 3-4 days [4,10]. When symptoms are present for less than 3-4 days PCR should be the test of choice, although PCR may be positive till 9 days after onset of symptoms [1],after this period IgM determination should be preferred.…”
Section: What Would We Be a Rational Approach For The Laboratory Diagmentioning
confidence: 99%
“…When symptoms are present for less than 3-4 days PCR should be the test of choice, although PCR may be positive till 9 days after onset of symptoms [1],after this period IgM determination should be preferred. The sensitivity of IgM is reported to be even higher if a convalescent serum is available taken 10 days after initial clinical presentation [10]. Despite frequently highly suggestive clinical presentation even in outbreak context, the overall rarity of mumps forces clinicians to seek for the laboratory confirmation.…”
Section: What Would We Be a Rational Approach For The Laboratory Diagmentioning
confidence: 99%
“…The virus specific IgM antibody can be measured by direct or indirect ELISA techniques 7-10 days after the onset of symptoms [41,51]. The sensitivity of IgM testing is variable, being as low as 24-51% in one study of five ELISA assays [51].…”
Section: Diagnosismentioning
confidence: 99%
“…The virus specific IgM antibody can be measured by direct or indirect ELISA techniques 7-10 days after the onset of symptoms [41,51]. The sensitivity of IgM testing is variable, being as low as 24-51% in one study of five ELISA assays [51]. In such settings, a four-fold rise in serum IgG titres between acute and convalescent phases of the virus is a useful indicator of active infection [43].…”
Section: Diagnosismentioning
confidence: 99%